Darers & Doers: The Quest for AI-Powered Cancer Vaccines
China Business Insider - News From Caixin Global
Release Date: 04/09/2026
Darers & Doers: The Quest for AI-Powered Cancer Vaccines
China Business Insider - News From Caixin Global
Program description: Darers and Doers, a special segment of China Business Uncovered, showcases groundbreaking innovations from China and features company founders and CEOs who are turning cool, bold ideas into reality. Produced by Caixin Global. Cancer treatment has long relied on a largely fixed set of options: surgery, radiation, chemotherapy and targeted drugs. But a new generation of biotech founders is trying to push the field toward something more precise — treatments built around the biology of a single patient. In this debut episode of Darers & Doers, Likang Life...
info_outline
China Business Uncovered Podcast #3: Inside the Fall of ‘China’s LVMH’
China Business Insider - News From Caixin Global
Program description: China Business Uncovered takes listeners inside China’s business world through the eyes of reporters who investigate it firsthand. Featuring open conversations with Caixin journalists, each episode breaks down the most complex developments inside Chinese companies. Tune in to understand how critical stories are covered, what’s really happening beneath the surface, and why it matters for businesses and investors operating in and around China. Recorded in Mandarin and produced in English with the help of AI, China Business Uncovered brings Caixin’s in-depth...
info_outline
China Business Uncovered #2: Brazil’s ‘Very Chinese Moment’
China Business Insider - News From Caixin Global
Program description: China Business Uncovered takes listeners inside China’s business world through the eyes of reporters who investigate it firsthand. Featuring open conversations with Caixin journalists, each episode breaks down the most complex developments inside Chinese companies. Tune in to understand how critical stories are covered, what’s really happening beneath the surface, and why it matters for businesses and investors operating in and around China. Recorded in Mandarin and produced in English with the help of AI, China Business Uncovered brings Caixin’s in-depth...
info_outline
China Business Uncovered Podcast #1: A $15 Billion Bitcoin Seizure and the Fall of a Cybercrime Kingpin
China Business Insider - News From Caixin Global
Program description: China Business Uncovered takes listeners inside China’s business world through the eyes of reporters who investigate it firsthand. Featuring open conversations with Caixin journalists, each episode breaks down the most complex developments inside Chinese companies. Tune in to understand how critical stories are covered, what’s really happening beneath the surface, and why it matters for businesses and investors operating in and around China. Recorded in Mandarin and produced in English with the help of AI, China Business Uncovered brings Caixin’s in-depth...
info_outline
Caixin Deep Dive: How a $15 Million Chinese Pork Deal Turned Into a Cautionary Tale for Foreign Investors
China Business Insider - News From Caixin Global
After investing in a Dalian meat company, a consortium of investors discovered their money had vanished, only to face obstacles from local authorities. (00:00:58) The Cross-Border Investor’s Nightmare Scenario (00:01:54) The $15.4 Million Bet on a Pork Empire (00:02:22) When the Lights Went Out: Filings Halt and Capital Vanishes (00:03:15) Bankruptcy Restructuring — Or a Shell Game? (00:04:04) A Zombie Company: Factory Alive, Equity Dead Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: ...
info_outline
Caixin Deep Dive: Chinese Local Governments Risk Replicating Mistakes of LGFVs
China Business Insider - News From Caixin Global
Culture-and-tourism investment companies emerge as a new financing channel for localities, but diverted funds and undistinctive projects leave many operating like LGFVs and facing the same financial pressures. Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a . Group discounts are available — contact us for a .
info_outline
Caixin Deep Dive: Chinese Firms Face Shifting Global IPO Landscape
China Business Insider - News From Caixin Global
Tighter rules proposed by the Nasdaq are expected to send some would-be issuers searching for more welcoming markets in London or Hong Kong. Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a . Group discounts are available — contact us for a .
info_outline
Caixin Deep Dive: Why Singapore Sovereign Fund Sues Chinese EV-Maker Nio
China Business Insider - News From Caixin Global
Nio shares slump in Singapore and Hong Kong after a Caixin report detailing GIC allegations. Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a . Group discounts are available — contact us for a .
info_outline
Caixin Deep Dive: Visa-Free Travel, U.S. Tariffs Drive Chinese Companies to Malaysia
China Business Insider - News From Caixin Global
Chinese investment is reshaping Malaysia, from booming flights to factory floors, as trade shifts and visa-free travel deepen business ties between Beijing and Kuala Lumpur. Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a . Group discounts are available — contact us for a .
info_outline
Caixin Deep Dive: Former Securities Regulator Yi Huiman’s Corruption Probe
China Business Insider - News From Caixin Global
While Yi was ICBC chairman, his son introduced a $4.5 billion CICC fund deal to the state-owned bank, sources tell Caixin. Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a . Group discounts are available — contact us for a .
info_outlineProgram description:
Darers and Doers, a special segment of China Business Uncovered, showcases groundbreaking innovations from China and features company founders and CEOs who are turning cool, bold ideas into reality. Produced by Caixin Global.
Cancer treatment has long relied on a largely fixed set of options: surgery, radiation, chemotherapy and targeted drugs. But a new generation of biotech founders is trying to push the field toward something more precise — treatments built around the biology of a single patient.
In this debut episode of Darers & Doers, Likang Life Sciences Founder and CEO Chen Li explains how his Beijing-based biotech startup is using artificial intelligence to develop personalized mRNA cancer vaccines.
Chen’s entrepreneurial journey began with the cancer diagnosis of his mother, who later became his company’s first patient. Ten years on, Likang’s product, LK101, is already being used on patients in South China’s Hainan province under a pilot policy, has won FDA approval, and is now advancing toward international clinical development.
Speaking with Caixin Global Managing Director Li Xin, Chen discusses how his approach aims to overcome the limits of current immunotherapy, how he sees the race between biotech startups and pharmaceutical giants, and why China’s biotech boom matters to the rest of the world.
Chapters:
(01:41) Why current cancer treatments aren’t enough
(04:44) Likang Life Science’s approach and success
(07:19) A founder’s personal mission
(10:56) Rethinking cancer treatment for solid tumors
(16:06) The race between startups and big players
(21:09) From China lab to FDA approval
(24:04) Real world clinical application and scaling up
(26:45) Why China’s biotech boom matters globally
This episode of Darers & Doers was recorded in Mandarin and produced in English with the help of AI.
Producers: Kelsey Cheng and Qing Na
Read more on Caixin Global:
Cover Story: Chinese Pharma Turns to Global Deals to Cure Capital Crunch
China Aims to Tame Cancer Gene Test Pricing With Bulk-Buying Plan
Subscribe now to unlock full access to Caixin Global and The Wall Street Journal for $200 a year. Group discounts are available — contact us for a customized plan.